Previous Article | Next Article 
Journal of Virology, February 1999, p. 1708-1714, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Distinct Recognition of Non-Clade B Human
Immunodeficiency Virus Type 1 Epitopes by Cytotoxic T Lymphocytes
Generated from Donors Infected in Africa
Lucy
Dorrell,1
Tao
Dong,1
Graham S.
Ogg,1
Simon
Lister,2
Steve
McAdam,1
Tim
Rostron,1
Chris
Conlon,3
Andrew J.
McMichael,1 and
Sarah L.
Rowland-Jones1,*
Molecular Immunology Group, Institute of
Molecular Medicine, John Radcliffe Hospital, Oxford OX3
9DS,1
Department of Genito-Urinary
Medicine, Imperial College School of Medicine, London W2
1PG,2 and
Nuffield Department of
Medicine, John Radcliffe Hospital, Oxford OX3
9DU,3 United Kingdom
Received 27 July 1998/Accepted 22 October 1998
We present detailed studies of human immunodeficiency virus
(HIV)-specific cytotoxic T-lymphocyte (CTL) responses to clade A or C
HIV type 1 in three donors infected in East Africa. We define several
novel non-clade B CTL epitopes, including some restricted by HLA
alleles common in Africans. Although cross-clade CTL recognition of
these epitopes does occur, recognition can also be highly clade specific.
*
Corresponding author. Mailing address: Institute of
Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United
Kingdom. Phone: 44-1865-222316. Fax: 44-1865-222502. E-mail:
sarah.rowland-jones{at}ndm.ox.ac.uk.
Journal of Virology, February 1999, p. 1708-1714, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Jennes, W., Camara, M., Dieye, T., Mboup, S., Kestens, L.
(2008). Higher Homologous and Lower Cross-Reactive Gag-Specific T-Cell Responses in Human Immunodeficiency Virus Type 2 (HIV-2) Than in HIV-1 Infection. J. Virol.
82: 8619-8628
[Abstract]
[Full Text]
-
Peters, H. O., Mendoza, M. G., Capina, R. E., Luo, M., Mao, X., Gubbins, M., Nagelkerke, N. J. D., MacArthur, I., Sheardown, B. B., Kimani, J., Wachihi, C., Thavaneswaran, S., Plummer, F. A.
(2008). An Integrative Bioinformatic Approach for Studying Escape Mutations in Human Immunodeficiency Virus Type 1 gag in the Pumwani Sex Worker Cohort. J. Virol.
82: 1980-1992
[Abstract]
[Full Text]
-
Geels, M. J., Dubey, S. A., Anderson, K., Baan, E., Bakker, M., Pollakis, G., Paxton, W. A., Shiver, J. W., Goudsmit, J.
(2005). Broad Cross-Clade T-Cell Responses to Gag in Individuals Infected with Human Immunodeficiency Virus Type 1 Non-B Clades (A to G): Importance of HLA Anchor Residue Conservation. J. Virol.
79: 11247-11258
[Abstract]
[Full Text]
-
Masemola, A. M., Mashishi, T. N., Khoury, G., Bredell, H., Paximadis, M., Mathebula, T., Barkhan, D., Puren, A., Vardas, E., Colvin, M., Zijenah, L., Katzenstein, D., Musonda, R., Allen, S., Kumwenda, N., Taha, T., Gray, G., McIntyre, J., Karim, S. A., Sheppard, H. W., Gray, C. M.
(2004). Novel and Promiscuous CTL Epitopes in Conserved Regions of Gag Targeted by Individuals with Early Subtype C HIV Type 1 Infection from Southern Africa. J. Immunol.
173: 4607-4617
[Abstract]
[Full Text]
-
Mwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G.-T., Beattie, T., Chen, Y.-H., Dorrell, L., McShane, H., Schmidt, C., Brooks, M., Patel, S., Roberts, J., Conlon, C., Rowland-Jones, S. L., Bwayo, J. J., McMichael, A. J., Hanke, T.
(2004). A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J. Gen. Virol.
85: 911-919
[Abstract]
[Full Text]
-
Hudgens, M. G, Gilbert, P. B, Self, S. G
(2004). Endpoints in vaccine trials. Stat Methods Med Res
13: 89-114
[Abstract]
-
Lopes, A. R., Jaye, A., Dorrell, L., Sabally, S., Alabi, A., Jones, N. A., Flower, D. R., De Groot, A., Newton, P., Lascar, R. M., Williams, I., Whittle, H., Bertoletti, A., Borrow, P., Maini, M. K.
(2003). Greater CD8+ TCR Heterogeneity and Functional Flexibility in HIV-2 Compared to HIV-1 Infection. J. Immunol.
171: 307-316
[Abstract]
[Full Text]
-
Novitsky, V., Cao, H., Rybak, N., Gilbert, P., McLane, M. F., Gaolekwe, S., Peter, T., Thior, I., Ndung'u, T., Marlink, R., Lee, T. H., Essex, M.
(2002). Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C. J. Virol.
76: 10155-10168
[Abstract]
[Full Text]
-
Novitsky, V., Smith, U. R., Gilbert, P., McLane, M. F., Chigwedere, P., Williamson, C., Ndung'u, T., Klein, I., Chang, S. Y., Peter, T., Thior, I., Foley, B. T., Gaolekwe, S., Rybak, N., Gaseitsiwe, S., Vannberg, F., Marlink, R., Lee, T. H., Essex, M.
(2002). Human Immunodeficiency Virus Type 1 Subtype C Molecular Phylogeny: Consensus Sequence for an AIDS Vaccine Design?. J. Virol.
76: 5435-5451
[Abstract]
[Full Text]
-
Currier, J. R., deSouza, M., Chanbancherd, P., Bernstein, W., Birx, D. L., Cox, J. H.
(2002). Comprehensive Screening for Human Immunodeficiency Virus Type 1 Subtype-Specific CD8 Cytotoxic T Lymphocytes and Definition of Degenerate Epitopes Restricted by HLA-A0207 and -CW0304 Alleles. J. Virol.
76: 4971-4986
[Abstract]
[Full Text]
-
Ndung'u, T., Lu, Y., Renjifo, B., Touzjian, N., Kushner, N., Pena-Cruz, V., Novitsky, V. A., Lee, T.-H., Essex, M.
(2001). Infectious Simian/Human Immunodeficiency Virus with Human Immunodeficiency Virus Type 1 Subtype C from an African Isolate: Rhesus Macaque Model. J. Virol.
75: 11417-11425
[Abstract]
[Full Text]
-
Novitsky, V., Rybak, N., McLane, M. F., Gilbert, P., Chigwedere, P., Klein, I., Gaolekwe, S., Chang, S. Y., Peter, T., Thior, I., Ndung'u, T., Vannberg, F., Foley, B. T., Marlink, R., Lee, T. H., Essex, M.
(2001). Identification of Human Immunodeficiency Virus Type 1 Subtype C Gag-, Tat-, Rev-, and Nef-Specific Elispot-Based Cytotoxic T-Lymphocyte Responses for AIDS Vaccine Design. J. Virol.
75: 9210-9228
[Abstract]
[Full Text]
-
Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., Detours, V.
(2001). Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull
58: 19-42
[Abstract]
[Full Text]
-
Moore, J. P., Parren, P. W. H. I., Burton, D. R.
(2001). Genetic Subtypes, Humoral Immunity, and Human Immunodeficiency Virus Type 1 Vaccine Development. J. Virol.
75: 5721-5729
[Full Text]
-
Buseyne, F., Chaix, M.-L., Rouzioux, C., Blanche, S., Rivière, Y.
(2001). Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gag Epitope by HIV-1-Infected Children. J. Virol.
75: 4941-4946
[Abstract]
[Full Text]
-
Goulder, P. J. R., Brander, C., Annamalai, K., Mngqundaniso, N., Govender, U., Tang, Y., He, S., Hartman, K. E., O'Callaghan, C. A., Ogg, G. S., Altfeld, M. A., Rosenberg, E. S., Cao, H., Kalams, S. A., Hammond, M., Bunce, M., Pelton, S. I., Burchett, S. A., McIntosh, K., Coovadia, H. M., Walker, B. D.
(2000). Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children. J. Virol.
74: 5679-5690
[Abstract]
[Full Text]
-
Ogg, G. S., Kostense, S., Klein, M. R., Jurriaans, S., Hamann, D., McMichael, A. J., Miedema, F.
(1999). Longitudinal Phenotypic Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes: Correlation with Disease Progression. J. Virol.
73: 9153-9160
[Abstract]
[Full Text]